Stay updated on Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial page.
Latest updates to the Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check10 days agoChange DetectedThe website has updated the intervention details and contact information for the Japan Breast Cancer Research Group, moving from version 2.13.3 to 2.14.0.SummaryDifference1%
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoNo Change Detected
- Check40 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check47 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference3%
- Check61 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference4%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference5%
Stay in the know with updates to Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial page.